Clinical Study Protocol of Transthyroxine Protein Amyloidosis Cardiomyopathy and Its Gene Carriers
Who is this study for? Adult patients with cardiomyopathy
What treatments are being studied? ATTR-CM
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
In this study, patients with ATTR-CM or gene carriers were selected to study the diagnosis and treatment, and long-term follow-up was conducted.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:
• Patients and gene carriers of ATTR-CM confirmed in the Second Affiliated Hospital of Zhejiang University School of Medicine, regardless of gender, age 18-90 years old;
• Patients who have the ability to understand the test and can cooperate with investigators
Locations
Other Locations
China
xiaohong University PAN
RECRUITING
Hangzhou
Time Frame
Start Date: 2021-06-01
Estimated Completion Date: 2031-06-01
Participants
Target number of participants: 100
Treatments
Experimental: ATTR-CM
Patients or Gene carrier
Related Therapeutic Areas
Sponsors
Leads: Second Affiliated Hospital, School of Medicine, Zhejiang University